Rigel Pharma (RIGL) Misses Q2 EPS by 1c
Rigel Pharma (NASDAQ: RIGL) reported Q2 EPS of ($0.16), $0.01 worse than the analyst estimate of ($0.15).
For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.
Rigel Pharma (NASDAQ: RIGL) reported Q2 EPS of ($0.16), $0.01 worse than the analyst estimate of ($0.15).
For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.